News
24 Nov 2016
Heparin
- Gaceta Médica and Hogarmanía came up second in their respective categories
- This contest recognized the best journalist works on heparin published in 2016, the year in which we are commemorating the discovery of this molecule
28 Sep 2016
Heparin
- The three organisations have signed a partnership agreement to explore new compounds derived from heparin, devoid of anticoagulant activity, in both humans and insects
- Heparin has been shown to play a dual role: as a targeting element of other antimalarial agents, and as an antimalaria drug
29 Aug 2016
Heparin
- Participants can present their articles and reports until 31 October.
- The jury is formed by four renowned professionals from communications, medicine and science
- The goal of the competition is to recognise the best journalistic publications about heparin and incentivise the work by professionals who report on health, economy and biotechnology in Spain
21 Jun 2016
Heparin
- Heparin is deemed a medical advance as important as penicillin
- 20% of the heparin administered worldwide is produced in Spain
- Heparin is the most used drug for the prevention and treatment of thrombosis, and it has been declared an essential drug by the World Health Organization
17 Jun 2016
Heparin
- Thrombosis is one of the most common causes of death, with more deaths attributable to it than to cancer, traffic accidents, or HIV
- One out of every five thromboses are associated with cancer
- Heparin is the most widely used drug for the prevention and treatment of thrombosis, and it has been declared “essential medicine” by the WHO